ArticlePharmaceuticals (Basel, Switzerland)2026

Synergistic Anti-Tumor Activity of LRPPRC Inhibition and Dasatinib Through Dual Oxidative Phosphorylation Disruption.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.